ASS1 and neoplasm: As the induction of autophagy in response to arginine deprivation may have a pro-survival role in patients with ASS1-deficient sarcomas, the combination of arginine deprivation therapy with autophagy modulators might potentiate anti-tumor effects in patients with drug-resistant sarcomas.